Record title

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Record identifier

TN_cdi_liege_orbi_v2_oai_orbi_ulg_ac_be_2268_300816

https://collection.sl.nsw.gov.au/record/TN_cdi_liege_orbi_v2_oai_orbi_ulg_ac_be_2268_300816

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

About this item

Full title

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2021, Vol.384 (14), p.1289-1300

Record Identifier

TN_cdi_liege_orbi_v2_oai_orbi_ulg_ac_be_2268_300816

Language

English

Formats

Publication information

Publisher

Subjects

Subjects and topics

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_liege_orbi_v2_oai_orbi_ulg_ac_be_2268_300816

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_liege_orbi_v2_oai_orbi_ulg_ac_be_2268_300816

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item